Cargando…

Safety and efficacy of switching from low molecular weight heparin to dabigatran in patients undergoing elective total hip or knee replacement surgery

BACKGROUND: The aim of this study was to assess the safety and efficacy of switching therapy from low molecular weight heparin (LMWH; enoxaparin) to dabigatran for prevention of venous thromboembolic events (VTE) in patients undergoing elective total hip or knee replacement surgery (THR/TKR). METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wurnig, Christian, Clemens, Andreas, Rauscher, Helmuth, Kleine, Eva, Feuring, Martin, Windhager, Reinhard, Grohs, Josef
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Original Clinical Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660827/ https://www.ncbi.nlm.nih.gov/pubmed/26612979 http://dx.doi.org/10.1186/s12959-015-0066-9

Ejemplares similares

Dabigatran etexilate for thromboprophylaxis in over 5000 hip or knee replacement patients in a real-world clinical setting
por: Rosencher, Nadia, et al.
Publicado: (2016)

Switching from enoxaparin to dabigatran etexilate: pharmacokinetics, pharmacodynamics, and safety profile
por: Clemens, Andreas, et al.
Publicado: (2012)

Changes of thrombelastography in patients undergoing elective primary total knee and total hip replacement with low molecular heparin prophylaxis
por: Yang, Yi, et al.
Publicado: (2014)

Oral Thromboprophylaxis Following Total Hip or Knee Replacement: Review and Multicentre Experience with Dabigatran Etexilate
por: Kendoff, D, et al.
Publicado: (2011)

Dabigatran approaching the realm of heparin-induced thrombocytopenia
por: Ho, Patricia J, et al.
Publicado: (2016)

Oral dabigatran etexilate versus enoxaparin for venous thromboembolism prevention after total hip arthroplasty: pooled analysis of two phase 3 randomized trials
por: Eriksson, Bengt I., et al.
Publicado: (2015)

Monitoring of Anticoagulant Activity of Dabigatran and Rivaroxaban in the Presence of Heparins
por: Jakimczuk, Aleksandra, et al.
Publicado: (2022)

Heparin dosing in uninterrupted anticoagulation with dabigatran vs. warfarin in atrial fibrillation ablation: RE-CIRCUIT study
por: Calkins, Hugh, et al.
Publicado: (2019)

Development of an occupational advice intervention for patients undergoing elective hip and knee replacement: a Delphi study
por: Baker, Paul, et al.
Publicado: (2020)

Type of anaesthesia and the safety and efficacy of thromboprophylaxis with enoxaparin or dabigatran etexilate in major orthopaedic surgery: pooled analysis of three randomized controlled trials
por: Rosencher, Nadia, et al.
Publicado: (2012)

Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons
por: Gómez-Outes, Antonio, et al.
Publicado: (2012)

No Influence of Dabigatran Anticoagulation on Hemorrhagic Transformation in an Experimental Model of Ischemic Stroke
por: Bohmann, Ferdinand, et al.
Publicado: (2012)

Safety of apixaban in Indian patients undergoing elective total knee replacement or total hip replacement surgery: A multi-center, phase-IV study
por: Panchal, Himanshu, et al.
Publicado: (2021)

What Opinions Do Tumor Reconstructive Surgeons Have about Sports Activity after Megaprosthetic Replacement in Hip and Knee? Results of the MoReSports Expert Opinion Online Survey
por: Hobusch, Gerhard M., et al.
Publicado: (2020)

Pituitary Apoplexy Following Elective Total Hip Replacement
por: Makadia, Aspin A, et al.
Publicado: (2023)

Reduced Awareness for Osteoporosis in Hip Fracture Patients Compared to Elderly Patients Undergoing Elective Hip Replacement
por: Kraus, Moritz, et al.
Publicado: (2022)

Fast-track program of elective joint replacement in hip and knee—patients’ experiences of the clinical pathway and care process
por: Berg, Urban, et al.
Publicado: (2019)

Can technology optimise the pre-operative pathway for elective hip and knee replacement surgery: a qualitative study
por: Sharif, Faraz, et al.
Publicado: (2020)

Simultaneous Pancreas-Kidney Transplantation in a Patient with Heparin-Induced Thrombocytopenia on Dabigatran Therapy
por: Jóźwik, Agnieszka, et al.
Publicado: (2018)

Long-term impact of sagittal malalignment on hardware after posterior fixation of the thoracolumbar spine: a retrospective study
por: Elshamly, Mahmoud, et al.
Publicado: (2020)

The Discovery of Dabigatran Etexilate
por: van Ryn, Joanne, et al.
Publicado: (2013)

Association of Medicare Mandatory Bundled Payment Program With the Receipt of Elective Hip and Knee Replacement in White, Black, and Hispanic Beneficiaries
por: Kim, Hyunjee, et al.
Publicado: (2021)

The impact of restricted provision of publicly funded elective hip and knee joints replacement during the COVID-19 pandemic in England
por: Penfold, Chris M., et al.
Publicado: (2023)

Hip arthroplasty fatality related to dabigatran induced gastrointestinal haemorrhage
por: Carter, A, et al.
Publicado: (2014)

Socioeconomic inequality, waiting time initiatives and austerity in Scotland: an interrupted time series analysis of elective hip and knee replacements and arthroscopies
por: Kirkwood, Graham, et al.
Publicado: (2022)

Pharmacometric Characterization of Dabigatran Hemodialysis
por: Liesenfeld, Karl-Heinz, et al.
Publicado: (2013)

The Outcomes of Total Hip Replacement in Patients with Parkinson's Disease: Comparison of the Elective and Hip Fracture Groups
por: Šponer, Pavel, et al.
Publicado: (2017)

Dabigatran, a direct thrombin inhibitor, can be a life-saving treatment in heparin-induced thrombocytopenia
por: Mirdamadi, Ahmad
Publicado: (2013)

Heparin ‘flush’ induced thrombocytopenia triggered by total hip replacement: a case report
por: Yoshida, Ruka, et al.
Publicado: (2020)

Total Hip and Knee Replacement in the Mature Athlete
por: Bloomfield, Michael R., et al.
Publicado: (2014)

Is Routine Hemoglobin Monitoring Necessary after Elective Hip and Knee Arthroplasty?
por: Hennessy, Orla, et al.
Publicado: (2020)

Lupus and Perioperative Complications in Elective Primary Total Hip or Knee Arthroplasty
por: Aziz, Keith T., et al.
Publicado: (2020)

Perioperative Management of Chronic Antithrombotic Agents in Elective Hip and Knee Arthroplasty
por: Santana, Daniel C., et al.
Publicado: (2021)

Cutaneous Ulcer Caused by Apixaban Treatment Is Resolved after Replacement with Dabigatran
por: Medoro, Alessandro, et al.
Publicado: (2022)

Cost-Utility Analysis of Venous Thromboembolism Prophylaxis Strategies for People Undergoing Elective Total Hip and Total Knee Replacement Surgeries in the English National Health Service
por: Dawoud, Dalia M., et al.
Publicado: (2018)

Obesity and long term functional outcomes following elective total hip replacement
por: Vincent, Heather K, et al.
Publicado: (2012)

Predicting Total Knee Replacement from Symptomology and Radiographic Structural Change Using Artificial Neural Networks—Data from the Osteoarthritis Initiative (OAI)
por: Heisinger, Stephan, et al.
Publicado: (2020)

Dabigatran in patients with atrial fibrillation: perioperative and periinterventional management
por: Weltermann, A., et al.
Publicado: (2012)

Dabigatran Acylglucuronide, the Major Metabolite of Dabigatran, Shows a Weaker Anticoagulant Effect than Dabigatran
por: Kim, Jong-Min, et al.
Publicado: (2022)

Heparin requirements for full anticoagulation are higher for patients on dabigatran than for those on warfarin – a model-based study
por: Edrich, Thomas, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_btcu9qa9bt6omfk6gfe0patlvk